𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Receptor for complement peptide C3a: a therapeutic target for neonatal hypoxic-ischemic brain injury

✍ Scribed by Järlestedt, Katarina (author);Rousset, Catherine I. (author);Ståhlberg, Anders (author);Sourkova, Hana (author);Atkins, Alison L. (author);Thornton, Claire (author);Barnum, Scott R. (author);Wetsel, Rick A. (author);Dragunow, Mike (author);Pekny, Milos (author);Mallard, Carina (author);Hagberg, Henrik (author);Pekna, Marcela (author)

Book ID
124058056
Publisher
The Federation of American Societies for Experimental Biology
Year
2013
Tongue
English
Weight
243 KB
Volume
27
Category
Article
ISSN
0892-6638

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Minocycline: A neuroprotective agent for
Minocycline: A neuroprotective agent for hypoxic-ischemic brain injury in the neonate?
✍ Kathryn M. Buller; Michelle L. Carty; Hanna E. Reinebrant; Julie A. Wixey 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 2 views

## Abstract Minocycline is a second‐generation tetracycline and a potential neuroprotective intervention following brain injury. However, despite the recognized beneficial effects of minocycline in a multitude of adult disease states, the clinical application of minocycline in neonates is contentio